South Korea Biopsy Devices Market
South Korea Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035
Industry Developments
The South Korea Biopsy Devices Market has seen significant developments in recent years. In October 2023, Medtronic announced advancements in its biopsy device technology aimed at improving precision and patient outcomes. Additionally, Johnson and Johnson introduced new minimally invasive biopsy techniques that gained traction among healthcare providers. The market presently continues to expand, with a notable increase in demand for advanced diagnostic tools among South Korean hospitals, contributing to an overall market valuation growth attributed to increasing healthcare expenditures and emphasis on early detection of diseases. Furthermore, in June 2023, Abbott Laboratories bolstered its presence in the South Korean market by entering a partnership with local healthcare institutions to enhance the use of its biopsy products. There have been no significant mergers or acquisitions reported for major players like Stryker and Hologic recently. However, press releases indicated ongoing collaborations among various companies as they aim to leverage emerging technologies such as artificial intelligence in biopsy procedures. Overall, the South Korea Biopsy Devices Market is in a dynamic phase of growth due to innovation and cooperative strategies between leading healthcare corporations.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 52.8(USD Million) |
| MARKET SIZE 2024 | 56.2(USD Million) |
| MARKET SIZE 2035 | 110.4(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.33% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Medtronic, Stryker, Abbott Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Hologic, GE Healthcare, Cardinal Health, AngioDynamics, C.R. Bard, Boston Scientific, B. Braun, Siemens Healthineers, Olympus, Cook Medical |
| SEGMENTS COVERED | Product Type, Application, Guidance, End User |
| KEY MARKET OPPORTUNITIES | Growing demand for minimally invasive procedures, Increasing prevalence of cancer cases, Advancements in imaging technologies, Rising healthcare expenditure, Expansion of diagnostics and research facilities |
| KEY MARKET DYNAMICS | Rising cancer incidence, Technological advancements, Increasing aging population, Growing healthcare expenditure, Enhanced diagnostic accuracy |
| COUNTRIES COVERED | South Korea |
FAQs
What is the expected market size of the South Korea Biopsy Devices Market in 2024?
The South Korea Biopsy Devices Market is expected to be valued at 56.2 USD Million in 2024.
What will be the market value of the South Korea Biopsy Devices Market by 2035?
By 2035, the South Korea Biopsy Devices Market is anticipated to reach a value of 110.4 USD Million.
What is the expected compound annual growth rate (CAGR) for the South Korea Biopsy Devices Market from 2025 to 2035?
The market is projected to grow at a CAGR of 6.33% from 2025 to 2035.
Which product type is expected to have the largest market share in 2024?
Biopsy Needles are expected to have the largest market share with a value of 17.5 USD Million in 2024.
What is the projected market size for Biopsy Guns in 2035?
The market size for Biopsy Guns is expected to reach 22.0 USD Million by 2035.
Who are the major players in the South Korea Biopsy Devices Market?
Key players include Medtronic, Stryker, Abbott Laboratories, Thermo Fisher Scientific, and Johnson & Johnson.
What market value does the Biopsy Guidance System hold in 2024?
The Biopsy Guidance System is valued at 9.0 USD Million in 2024.
What is the expected growth rate for the Biopsy Forceps segment from 2025 to 2035?
The Biopsy Forceps segment is projected to experience significant growth, reaching a market value of 20.5 USD Million by 2035.
What challenges does the South Korea Biopsy Devices Market face?
Challenges include regulatory hurdles and the need for technological advancements in biopsy procedures.
Are there any emerging trends in the South Korea Biopsy Devices Market?
Emerging trends include increased usage of minimally invasive techniques and advancements in imaging guidance systems.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment